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Mass spectrometryPhosphorylation of serine, threonine and tyrosine plays signiﬁcant roles in cellular signal transduction and in
modifying multiple protein functions. Phosphoproteins are coordinated and regulated by a network of kinases,
phosphatases and phospho-binding proteins, which modify the phosphorylation states, recognize unique
phosphopeptides, or target proteins for degradation. Detailed and complete information on the structure and
dynamics of these networks is required to better understand fundamental mechanisms of cellular processes
and diseases. High-throughput technologies have been developed to investigate phosphoproteomes in model
organisms and human diseases. Among them, mass spectrometry (MS)-based technologies are the major plat-
forms and have been widely applied, which has led to explosive growth of phosphoproteomic data in recent
years. New bioinformatics tools are needed to analyze and make sense of these data. Moreover, most research
has focused on individual phosphoproteins and kinases. To gain a more complete knowledge of cellular process-
es, systems biology approaches, including pathways and networks modeling, have to be applied to integrate
all components of the phosphorylation machinery, including kinases, phosphatases, their substrates, and
phospho-bindingproteins. This reviewpresents the latest developments of bioinformaticsmethods and attempts
to apply systems biology to analyze phosphoproteomics data generated by MS-based technologies. Challenges
and future directions in this ﬁeld will be also discussed.
© 2014 Liu andChance. Published by Elsevier B.V. on behalf of the Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Contents1. Phosphosite localization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
2. Phosphoproteomics data resources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
3. Functionality and evolution of phosphosites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
4. Phosphorylation and phospho-signaling networks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
5. Integrating phosphoproteomics with other data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
6. Challenges and future directions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95The reversible phosphorylation of amino acid side chains is one of the
most common and important post-translational modiﬁcations (PTM) of
proteins. Current studies aremainly focused on phosphorylation of serine
(Ser), threonine (Thr), and tyrosine (Tyr), though other amino acids can
also be phosphorylated such as histidine (His), aspartate (Asp), cysteine
(Cys), lysine (Lys) and arginine (Arg). The latter side chain modiﬁcations
are much less studied due to either lower frequency or experimental
difﬁculties. Protein phosphorylation can result in changes of protein
structure, activation/inhibition of protein activities, and promotion/r B.V. on behalf of the Research Ne
/licenses/by/4.0/).prevention of protein–protein interactions [1,2]. Consequently, protein
phosphorylation is one of the key regulatory mechanisms inherent in
many important cellular processes, such as cell signaling, growth, and
proliferation while abnormal phosphorylation can lead to serious dis-
eases, such as cancer, diabetes and rheumatoid arthritis [3–5]. Thus, a bet-
ter understanding protein phosphorylation will help to improve our
knowledge of important cellular processes, provide a better under-
standing of disease mechanism, and drive the development of efﬁcient
treatments and new biomarker strategies.
More than 30% of human proteins are seen to be phosphorylated,
these modiﬁcations often occur on multiple distinct sites [6]. Most of
phosphoproteins are at substoichiometric concentrations with respecttwork of Computational and Structural Biotechnology. This is an open access article
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and transient. To systematically study phosphoproteins, several high-
throughput phosphoproteomic technologies, such as reverse phase pro-
tein array, phospho-speciﬁc ﬂow cytometry, and mass spectrometry
(MS) based technologies have been developed as summarized in recent
reviews [7,8]. Among them, MS based technologies have becomemajor
platforms that have been routinely applied to identify phosphoproteins
and phosphosites at a global, unbiased, and quantiﬁable level [9–13]. In
a typical MS-based phosphoproteomic experiment, the procedure can
be divided in four stages: sample preparation, including cell fraction-
ation and protein digestion; enrichment of phosphopeptides via afﬁnity
puriﬁcation; analysis via liquid chromatography (LC) coupled with tan-
dem MS; and ﬁnally, localization and quantiﬁcation of phosphosites/
phosphoproteins using bioinformatics approach (summarized in
Fig. 1). Recently, several excellent articles have reviewed the techni-
cal details of phosphoproteomic experiments, i.e., the ﬁrst three steps
[14–16]. In this review,we focus on the latest developments of bioinfor-
matics approaches to annotate and integrate phosphoproteomic data,
including phosphosites identiﬁcation, comparative study of phospho-
proteins, and construction of phosphorylation networks.
Systems biology is a relative new ﬁeld that studies the properties
and models of biological systems from systematic measurements,
i.e., the “omics” data from high-throughput experiments. Systems biol-
ogy approaches aim to reveal the property and behavior of dynamic and
complex biological systems in the system level instead of individual
parts [17]. Network construction and modeling are very important
parts of systems biology; while signal transduction plays essential
roles in the regulation and coordination of networks, and is in many
cases mediated by protein phosphorylation [4,5]. Protein kinases and
phosphatases are essential components of phosphorylation process:
kinases add phosphate groups to their substrates; while protein phos-
phatases facilitate the reverse reaction. Pathways for protein phosphor-
ylation are large and interconnected networks, involving kinases,
phosphatase and their substrates. Large amounts of phosphoproteomics
data generated from high-throughput experiments make it possible to
construct a range of cell type, tissue, organism, and disease-speciﬁc
phosphorylation networks, and they have allowed us to investigate
the functional phosphorylation associated signaling states. In this
review, we will present the recent progress in this exciting ﬁeld.Fig. 1. Summary of MS-based phos1. Phosphosite localization
MS/MS spectra generated fromphosphoproteomics experiments are
used to identify phosphopeptides by applying database search tools,
such asMASCOT [18] and SEQUEST [19]. However, most search engines
are not designed or optimized for identiﬁcation of phosphopeptides,
and they don't provide reliable conﬁdence levels for the exact localiza-
tion of possible phosphosites (i.e., the identiﬁcation of exact amino
acids phosphorylated). This becomes crucial if there are two or more
potential phosphosites in detected peptides. The situation becomes
even more complicated when the phosphopeptides have low abun-
dance and when intense neutral loss peaks in the MS/MS spectra dom-
inate signals of interest. Statistical methods have been developed to
score the reliability of phosphosite localization using one of two follow-
ing strategies as reviewed in [20]: estimating the probability of each
candidate phosphosite based on site-determining ions in MS/MS
spectra, examples include the popular A-score [21] and PTM score
[9]. Alternate methods include calculating a score based on the dif-
ference of database search outputs between different site assign-
ments for a given phosphopeptide, as implemented in Mascot Delta
Score [22] and SLIP score [23]. In this section, we present details of
these methods, recent developments, and results from the compari-
son of different phosphosite localization methods.
Gygi and colleagues proposed the A-score, a measurement of the
conﬁdence for the correct phosphosite localization in a given peptide
that has two or more potential phosphosites [21]. First, based on the
peptide sequence, fragment ions that are able to uniquely assign a spe-
ciﬁc phosphosite are identiﬁed and termed “site-determining ions”;
then, in the corresponding MS/MS spectrum, the site-determining
ions matched peaks are identiﬁed and counted for each possible
phosphosite; the cumulative binomial probability is calculated using
the total number of site-determining ions and the number of matched
ions; ﬁnally, the probabilities for the top two candidates are used to
calculate A-score by formula−10 × log(P1) + 10 × log(P2), where Pi
is the probability for the best two candidates [21]. The PTM sore is cal-
culated in a very similar way [9], the major difference is the selection
of ions: all detected ions are used to calculate PTM score; in the case
of A-score only “site-determining ions” are used. Taus et al., observed
that the density of peaks in different regions is different across eachphoproteomics experiments.
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od by taking this into account [24].
More recently, Nesvizhskii and colleagues developed LuciPHOr,
which uses mass accuracy (m/z) and peak intensities for phosphosite
localization scoring [25]. LuciPHor is based on the principle that the dis-
tribution of peak intensity and m/z for random peaks and peaks with
fragment ions are distinguishable, and an odds ratio can be calculated
for each peak. There are four steps to compute LuciPHOr score: peak
assignment, dynamic training, computing odds ratio, and score calcula-
tion. First, peaks with matched ions and random peaks are identiﬁed;
then, distribution of the intensity and m/z for matched peaks and
random peaks are established in the dynamic training step separately.
The log odds of a matched peak can be computed using the deter-
mined distribution for each peak; a cumulative log odds for a spec-
trum (i.e. scores for all matched ion in a spectrum are summed up)
can be assigned to each candidate site, and the ﬁnal LuciPHOr score
is the difference of cumulative log odds between the top two candidate
sites. The authors claimed that LuciPHOr identiﬁed more correct phos-
phosites at equivalent false location rates compared to A-score and
Mascot Delta Score [25].
The search engines utilized by phosphoproteomics consider all pos-
sible phosphosites in a peptide, and provide an identiﬁcation score for
each phosphopeptide. Thus, the score from a search engine can be
used to estimate the site localization reliability. Beausoleil et al.ﬁrst pro-
posed the normalized Mascot delta score (i.e., the difference between
the top twoMascot scores divided by the best Mascot score) for scoring
the phosphosite localization and found that its performance was inferi-
or comparedwith A-score [21]. However, Savitski et al. showed that the
Mascot Delta score (MD-score, the difference between the top twoMas-
cot scores) achieves similar performance with A-score, and the perfor-
mance of normalized Mascot delta score is impaired by the low
quality search results [22]. Methods for other search engine and
engine-independentmethods have been developed [23,26]. One serious
drawback of this type method is that the scores of two possible phos-
phosites are very similar, even equal, for around 10% of the cases.
Thus, this method cannot distinguish them.
The performances of different methods for phosphosite localization
have been compared in several studies. Marx et al. showed that MD-
score, phosphoRS and PTM score have overall similar accuracies, but
the results are complementary among these approaches, which implies
that there is still room for improvement [27]. This and other studies also
demonstrated that localization methods have to be adjusted based on
experimental designs (e.g., low vs. highmass accuracy or electron trans-
fer dissociation vs. higher collisional dissociation) [25,27,28]. However,
the performances of various phosphosite localization methods have
not been validated by extensive experimental examination.
False localization rate (FLR) is a general and useful concept to mea-
sure the reliability of phosphosite localization though accurate estima-
tion of the FLR is challenging because peptides can have signiﬁcantly
different uncertainty in phosphosite localization [20]. Furthermore,
the incorrect phosphosite localizations are not randomly distributed
across peptides; they are often near neighbors to the correct sites. Con-
sequently, the use of decoy sequences, which are commonly used for
measuring the reliability of peptide and protein identiﬁcation, cannot
provide accurate estimation for the error of phosphosite localization.
To estimate these errors, approaches of phosphorylation estimation in
silico have been developed, which computationally phosphorylates
amino acid residues that typically do not occur in nature [23,25]. How-
ever, theﬁeld of FLR calculation is still in its early stages, andmore study
is critical for improved phosphoproteomics analyses.
2. Phosphoproteomics data resources
After phosphosites are determined by localization methods,
many are deposited into public repositories. Due to recent advances
in technologies, the amount of phosphoproteomics data in the publicdepositories has been growing exponentially in recent years [29].
In this section, we will present an overview of data resources in
phosphoproteomics including phosphosite databases and phosphor-
ylation networks.
Over the last decade, many public depositories have been developed
to store phosphosite information, including Phospho.ELM [30] and
phosphoSitePlus [31], which are commonly used in phosphoproteomics
studies. Phospho.ELM contains experimentally identiﬁed phosphoryla-
tion sites in eukaryotic proteins; the current version (April, 2014) is
9.0, which contains 42,573 phosphosites for 8718 phosphoproteins.
The current phosphoSitePlus has 144,042 phosphosites for 16,390 pro-
teins, and it also includes other PTM sites, such as 12,300 acetylation
sites. There are two major differences between these two resources. 1)
Phospho.ELM focuses more on human: the proportions of protein in-
stances are Homo sapiens (62%) and Mus musculus (16%), while the
numbers are 51% and 42% for phosphoSitePlus. 2) phosphoSitePlus
coversmuchmore journals and papers (over 13,000 papers and 600 dif-
ferent journals), and it adds unpublished results from Cell Signaling
Technology research groups. Some general databases also contain phos-
phorylation information for many proteins, such as HPRD [32] and
UniProt [33], while databases for some speciﬁc organisms have also
been developed, like PhosPhat for Arabidopsis thaliana [34], P3DB for
six plants species [35] and phosphoPep for Drosophila [36]. Many
post-translational modiﬁcation (PTM) databases include phosphosite
information since it is the most common PTM; examples are Phosida
[37], SysPTM [38] and dbPTM [39].
Cataloging phosphosites can help to understand mechanisms of
signaling and interactions; however other information is also needed,
like the corresponding kinases and phosphatases that are active
towards the known phosphosites. These can be used to create wide-
ranging phosphorylation networks. The most reliable and extensive in-
formation to date is on kinase–substrate networks. High-throughput
technologies and computational approaches have been developed to
identify these relevant kinase–substrate relationships, and the results
are deposited into network databases, like phosphoNetworks and
phosphoPOINT [40–42]. PhosphoNetworks contains high-resolution
phosphorylation networks derived from protein microarray and MS-
based experiments, and it integrates a range of approaches to store,
visualize, and analyze phosphorylation data [41]. The phosphorylation
networks in PhosphoNetworks connect 230 human kinases with 2591
phosphorylation sites on 652 substrate proteins. Using a computational
approach to integrate phosphoproteomics, protein interaction, and
gene expression data, Yang et al. established phosphoPOINT, a database
of the interactions among kinases, their potential substrates, and
interacting proteins [42]. phosphoPOINT includes 4195 phospho-
proteins, 518 kinases, and their corresponding protein–protein interac-
tion (PPI) partners.
Complementary to identiﬁcation of phosphosites by high-throughput
experiments, computational methods have been previously developed
to predict phosphosites [43]. Many state-of-the-art machine-learning
approaches have been used to predict phosphosites, including artiﬁcial
neural network [43], support vector machine [44], and random forest
[45]. Besides protein sequences, some methods also used structural
and evolutionary information to improve predictions [37,43,46]. The
available methods and challenges in this ﬁeld have been reviewed and
compared for phosphorylation site prediction in recent articles [47,48].
Although phosphoproteomics data have increased dramatically in
public repositories, it is important to note that the majority of the data
are generated from high-throughput technologies and not validated
by methods with higher accuracy. Thus, these databases thus have
several problems associated with them aside from potentially inaccu-
rate site identiﬁcation. First, we do not know the proportion of phos-
phosites that are functionally active as opposed to sites that are
modiﬁed by off-target effects of kinases. This is discussed extensively
below. Second, phosphosite localization might not be correct if neigh-
boring potential phosphosites exist. Third, there is minimal information
Fig. 2.Mechanisms of modulating protein function by phosphorylation.
93Y. Liu, M.R. Chance / Computational and Structural Biotechnology Journal 10 (2014) 90–97on the stoichiometry of phosphosites in current databases, due to the
difﬁculty of quantiﬁcation. Such information is very important and
can provide clues on the signiﬁcance of the phosphorylation. High-
throughput methods to measure phosphorylation stoichiometry have
been proposed recently [49], but the performance has not been exten-
sively examined.
3. Functionality and evolution of phosphosites
Over 150,000 phosphosites have been documented in databases,
and we expect that the number will continue to increase rapidly. How-
ever, the functional effects of most of them have not been investigated
with sufﬁcient care to fully understand their signiﬁcance. Recently, it
was proposed that some phosphosites have little or even no biological
functional effect at all [50]. This concept can be compared to that of
“driver/passenger” mutations in cancer genome [51]. In this respect
there may be “driver” phosphorylations that are most important for
mediating functional changes as well as “passenger” phosphorylations,
which occur due to the normal operation of the cellular machinery but
have little or no effect on the regulatory functions. One of the arguments
to support this proposal is the lack of evolutionary conservation for
some phosphosites. This section presents the recent development on
the comparative phosphoproteomics along with the debates about the
non-functional phosphorylation.
Landry et al. compared the phosphoproteomes of yeasts and verte-
brates and found that phosphoproteomes evolve rapidly in these two
lineages, and phosphosites with known functions are much more con-
served than those without annotated functions [52]. They estimated
that around 65% of phosphosites is not conserved. By comparison, for
human vs. mouse orthologs, another study reported that 10–15% phos-
phosites are found not to be under strong constraint [37]. It was pro-
posed that the non-conserved phosphosites might be non-functional
[50,52,53]. However, other studies demonstrate that the functional
phosphosites might not be necessarily conserved, and rapidly evolving
phosphoproteomes could play important roles in evolution [54].
Furthermore, evolutionary constraints might act at the phosphorylation
network level, instead of at the level of individual phosphorylated
sequences [55,56].
By analyzing 308 substrates of cyclin-dependent kinas Cdk1 in yeast,
Holt et al. found that 90% of phosphosites is in loops and disordered
regions of proteins, and the “phosphorylated regions” are conserved
across yeast species (i.e., the same loop regions are phosphorylated),
but the positions of phosphosites are much less constrained [54]. At
least two major mechanisms have been proposed for phosphorylation
to regulate protein function: conformation change and phosphopeptide
binding [4], as illustrated in Fig. 2. Precise conformation changes require
the exact sites to be phosphorylated (i.e., the phosphosites arewell con-
served across species). On the other hand, phosphopeptide-mediated
binding mechanisms may not have such strong requirements and
sequence alignments in fact are challenging in these regions. Thus,
the authors proposed that Cdk1 modiﬁes substrate functions by
phosphopeptide-binding mechanisms: the addition of phosphates
to a protein sub-domain disrupts or generates interactions with other
proteins and the phosphorylation provides a general guide (or repul-
sion) for signaling the binding partner [54]. The authors also suggested
that the less conserved phosphosites could help to generate new regu-
latory mechanisms [54].
Tan et al. compared the human phosphoproteome with distantly
related species (ﬂy, worm and yeast) and identiﬁed 479 phosphosites
that were conserved between human and at least one other species,
which represents only 11% of 4448 human phosphosites [55]. The corre-
sponding kinases for the 479 conserved phosphosites were identiﬁed
using a computational approach [57], and conserved kinase–substrate
networks (778 phosphorylation events in 698 human proteins) were
constructed. Their results demonstrated that part of phosphorylation
events is conserved at both sequence and network levels. However,although it is plausible that the conserved sites are functional, the con-
verse is not necessarily true; i.e., the non-conserved sites are not neces-
sarily nonfunctional. Nevertheless, their study suggests the importance
of considering the phosphorylation networks instead of phosphosites
alone.
4. Phosphorylation and phospho-signaling networks
Phosphorylation events can be portrayed as products of phosphory-
lation networks,which consist of kinases, their substrates, and their cor-
responding functional relationships. Many kinase substrates are also
kinases, and in many cases, kinases are auto-phosphorylated. Thus,
kinases are highly regulated by phosphorylation, and the phosphoryla-
tion networks are complex and an important part of signalingpathways.
Numerous studies have attempted to construct and characterize phos-
phorylation networks using both experimental and computational
approaches inmodel organisms anddiseases [9,12,13,40,55,58–64]. Sig-
niﬁcant insights have been gained through these studies. For example,
phosphoproteomics studies of stimulated HeLa cells demonstrated
that protein phosphorylation can regulate the transcription levels of
many downstream targets, and phosphosites are regulated differently
within the same protein, suggesting that functional effects of phos-
phosites within a protein are site-dependent [9]. Another lung cancer
phosphoproteomics study found different combination of activated
kinases in different cancer patients, implying the importance of the
personalized treatments [12]. In a recent review, Liu et al., summarized
the methods to construct phosphorylation networks and outlined
recent developments of identifying phospho-signatures from phos-
phorylation networks [65]. To avoid redundancy, this section will
focus on recent developments of phosphorylation-associated signal-
ing networks (phospho-signaling networks).
Phospho-signaling networks are the networks and pathways in
which phosphorylation plays a signiﬁcant role inmediation of the signal
transduction. Phosphorylation networks are part of phospho-signaling
networks in which there are multiple important components, such as
protein kinases, phosphatases, and their substrates, and phospho-
binding proteins. The relationship among kinases, phosphatases, and
Fig. 3. Relationships among kinase, phosphatase and phospho-binding protein. Note that the phosphoprotein and phospho-binding protein could also be a kinase or phosphatase, which
makes for a quite sophisticated phospho-signaling network.
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opposite function of kinases: they remove the phosphate group from
phosphoproteins by hydrolyzing phosphoric acid monoesters into a
phosphate ion and a molecule with a free hydroxyl group. Kinases
have been the focus of research due to their importance in signaling,
while phosphatases were considered more passive housekeeping
enzymes and not as important as kinases. However, recent studies
clearly show that both kinases and phosphatases are very important
for signal transduction: in many cases, kinases control the amplitude
of the signal while phosphatases govern the rate and duration of
the signal [66–68]. Thus, phosphatase databases and phosphatase–
substrate networks have been developed to facilitate the study of
phospho-signaling networks [69–72]. Based on the substrates, phos-
phatases can be divided into tyrosine-speciﬁc, serine/threonine-
speciﬁc, dual speciﬁcity phosphatases, and others such as lipid phos-
phatases. There are 226 human phosphatases known to date, and
around 100 of them are classiﬁed as tyrosine-speciﬁc, implicating that
phosphatases are important for phospho-tyrosine related signal trans-
duction [67,69–71,73]. Interestingly, the number of known tyrosine
kinases encoded in human genome is similar with the number of tyro-
sine phosphatases [1] (110 tyrosine kinase, and 100 tyrosine-speciﬁc
phosphatases). By contrast, only 38 out of 226 human known phospha-
tases are serine/threonine-speciﬁc, but there aremore than 400 kinases
with known or predicted function to phosphorylate serine/threonine
[70]. Protein phosphatase 1 (PP1) and protein phosphatase-2A (PP2A)
are responsible for most dephosphorylation reactions counteracting
the effects of hundreds of kinases. Their crucial roles in modifying pro-
tein functions and in phospho-signaling networks are now beginning to
be appreciated [70]. The sequence analysis of phosphatase targets show
that the +1 position is preferred as proline for some phosphatase
(CDC14A, CDC14B, SCP, PP5, PP2B, and PP2A), but it is not the exclusive
substrate speciﬁcity: PP5, PP2A and PP2B recognize othermotifs aswell
[70,74–76]. Furthermore, in general, the substrate speciﬁcity is weak for
most phosphatases (particularly serine/threonine-speciﬁc phospha-
tases), suggesting the catalytic domains might be guided to act on
their substrates by complex mechanisms [77], for example PP2A has
multiple regulatory subunits that likely control speciﬁcity [78].
Phosphatases and kinases can share substrates and docking sites
or even interact directly, and biological insights can be gained through
investigating these relationships. For example, in a global protein kinase
and phosphatase interaction network of budding yeast, phosphatase
CDC14 interacts with around 20 kinases and ﬁve other phosphatases,
indicating its signiﬁcance for kinase signaling and DNA damage
response [79]. Another study showed that CDC14A/B and cyclin-
dependent kinases (CDKs) share several common substrates, con-
ﬁrming that CDC14A/B plays a role in cell cycle regulation [70]. In
the case of common substrates, simulation studies demonstrated that
the phosphorylation states can reach distinct steady states and the num-
ber of such states increases with the number of phosphosites, which
highlights the effects of the interactions between kinases and phospha-
tases [80]. Furthermore, overlapping or common docking sites for kinaseand phosphatases suggests a competitionmechanism for regulating the
phosphorylation states of the shared substrates [81–83].
Phospho-binding proteins are another important component of
phospho-signaling networks. One characteristic feature of cellular signal-
ing is the separation of enzyme activity from target recognition. Target
recognition is often achieved by the cooperation of proteinswith binding
domains and proteins with target motif sequences. The Src homology-2
or SH2 domain is one well-characterized peptide-binding domain,
and it recognizes and binds phosphotyrosine residues in speciﬁc
sequence contexts [4]. There are 111 human proteins containing SH2
domains, which can be divided into 38 families based on sequence [84].
Other widespread phospho-binding domains include phosphotyrosine-
binding (PTB), 14-3-3, and forkhead-associated (FHA) domains
[85–87]. These proteins have diversiﬁed functions, such as kinase, phos-
phatase, transcription factor, and regulation of cytoskeletal architecture
and cell adhesion. Thus, they play signiﬁcant roles in phospho-signaling
networks. Proteins without phospho-binding domains can also be affect-
ed by phosphorylation, which is the case for proteins with PDZ or SH3
domain. The recognition target of both domains has Ser or Thr, whose
phosphorylation can inﬂuence the domain interactions and consequently
result in uncoupling of signaling [88–90]. Thus, the study of phosphoryla-
tion on signaling should go beyond kinase/phosphatase and substrates
and apply a systems biology approach that integrates multiple potential
interactions, each of which contains a different slice of information [17].
Although the importance of both phosphatases and phospho-
binding proteins in signaling pathways has been accepted in recent
years [4,73], the studies are still far less comprehensive compared to
those of kinases. To complete our knowledge of signaling processes
and diseasesmechanism,muchmorework on these important proteins
are needed to identify their functions, substrates, and effects using sys-
tems biology approaches in particular. Systems biology approaches and
the construction of phospho-signalingnetworks can also reveal the high
level properties of systems, improve our understanding of diseases, and
help develop new biomarkers and treatments. In a recent study,
Koytiger et al. developed a protein microarray technology to systemat-
ically investigate interactions between human proteins with SH2 or
PTB domain and receptor/adaptor proteins with phosphotyrosines [91,
92]. They constructed a protein–protein interaction network, and
found that it has a very high degree of connectivity, and many hub
nodes arewell-know oncogene, moreover, some of them are the prima-
ry targets of newanticancer drugs (e.g. EGFR, ERBB2, RET, KIT and ABL1)
[92].
5. Integrating phosphoproteomics with other data
Various high throughput technologies have been developed and
widely applied to proﬁle different types of cellular components, such
as microarray and next generation sequencing for DNA or mRNA, and
high-resolutionMS for proteins and protein–protein interactions. Com-
bination of these technologies can generate various types of omics data
from the same cell type or individual, and integratingdiverse omics data
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or diseases [93,94]. However, integrating diverse type of data is always
challenging due to the differences in the technological methods
and complexity of cellular process, which include post transcription
regulation and post-translational modiﬁcation [95]. Recently, several
studies proposed new methods to integrate phosphoproteomics with
other data to investigate signaling pathways. In complex diseases like
cancer, mutated genes can dysregulate several pathways simultaneous-
ly; this consequently leads to dramatic changes in levels ofmany genes/
proteins, such as mRNA expression, protein abundance, and phosphor-
ylation states [92,96,97]. To identify the dysregulated gene/proteins and
pathways in cancer cells, Balbin et al. have attempted to integrate
phosphoproteomics with transcriptomics, and proteomics [98]. They
developed a novelmethod to identify proteins and pathways associated
with mutated KRAS in non-small cell lung cancer (NSCLC) cell lines.
To overcome the low overlap among data sets (only two differentially
expressed proteins shared among three data sets at the level of
corrected p-value 5%), they designed a metric S to identify tran-
scripts, proteins and phosphoproteins with differential abundances
uniquely or consistently seen across different data sets. First, the log-
transformed fold changes (LFC) of each protein/gene was computed,
and z-transformed for each data set separately. Then, the S score of
one protein is theweighted sumof z-transformed LFC;while theweight
is a function of the size of data set. Using this metric, 115 differentially
abundant proteins were identiﬁed at adjusted P-value 5% level. Further
pathway analyses based on these 115 proteins suggested an active and
targetable subnetwork composing of KRAS, MET, LCK and PAK1 in
KRAS-dependent NSCLC cell lines [98].
In another study, phosphosites detected by phosphoproteomics
have been integrated with cancer genomics data to study the phos-
phorylation signaling in cancer. Reimand et al. developed ActiveDriver,
a method to identify frequently mutated phosphosites and genes/
proteins in cancer [99]. The method is based on linear regression
and applies likelihood ratio test to identify genes that have phospho-
sites with unexpected high mutation rates. ActiveDriver was applied
to 87,060 known phosphosites and mutation data from The Cancer
Genomics Atlas (TCGA) and identiﬁed 150 known or candidate can-
cer genes whose phosphosites are affected by the mutations [100].
Further analysis showed that those mutations likely led to rewiring
of the involved signaling pathways.
Phosphoproteomics has also been integrated with PPI network to
reveal network properties of phosphoproteins. Yachie et al. integrated
yeast phosphoproteome with protein structure, proteome abundance,
and PPI networks to investigate the effects of phosphorylation on pro-
tein interaction patterns [101]. They suggest that phosphoproteins
havemore interactions than other proteins, and the interacting partners
of phosphoproteins aremore diversiﬁed, implying that phosphorylation
makes a large contribution to PPI diversity and might have signiﬁcant
roles other than signaling. They also found that interacting proteins
tend to be phosphorylated together most likely by the same kinase.
Phosphorylation is only one of dozens frequent PTMs; others include
glycosylation, acetylation,methylation, ubiquitination, and SUMOylation.
Recent studies revealed extensive crosstalk and interplay between
phosphorylation and other PTMs [14,102], for example, the competition
between phosphorylation and O-linked glycosylation for Ser and Thr
[103–105]; and the promotion/inhibition of ubiquitination by phos-
phorylation [106]. Recent studies investigated the co-evolution and
functional association of PTMs, and constructed a network of associated
PTMs that regulates multiple functional states of proteins [107,108]. By
integrating protein interaction networkswith several PTMs,Woodsmith
et al. found that multiple PTMs are enriched in some disordered
regions, which have high mutation rate in cancer and can be impor-
tant for cellular processes [109]. New high throughput methods have
developed to enrich phosphorylation, ubiquitylation and/or acetylation
for same sample, and enable the integrated analysis for different PTMs
[110,111]. However, currently sensitive and robust high throughputapproaches are available only for few types of PTM, new reliable
methods are needed to study the interplay and crosstalk of all common
PTMs.
6. Challenges and future directions
Several challenges still remain to be tackled in the phosphoproteomics
ﬁeld. Due to the limitation of current technologies, many phospho-
sites have yet to be discovered, and knowledge is limited for themajority
of known phosphosites, e.g., lack of functional annotation and abun-
dance information. Moreover, other type of phosphosites, such as
phosphohistidine, is much less studied. Histidine phosphorylation
was discovered ﬁve decades ago, reported to present in both prokaryotes
and eukaryotes, and might be more common than phosphotyrosines
[112]. Studies showed that it plays signiﬁcant role in signaling processes
in some species and is implicated in certain human diseases. Detection
of phosphohistidine is challenging due to its chemical instability [113].
However, recent discovery of phosphohistidine antibodies might pro-
vide a valuable method to tackle this challenge [114].
Another challenge is the identiﬁcation of functionally important
phosphosites. Although the proposal of nonfunctional phosphorylation
is controversial, some phosphosites likely have more important roles
than others. Several computational methods have been developed to
distinguish those impotent ones based on the protein structure, but
their performance is hard to evaluate [115,116].
As mentioned above, the phospho-signaling network is composed
of phosphoproteins, kinases, phosphatases, and phospho-binding pro-
teins. Phosphoproteomics experiments provide large amounts of infor-
mation about phosphoproteins but minimal information for other
components. Computational methods based on motif sequences or PPI
network have been developed for prediction of kinases that is associated
with phosphosites [57,117], but themethod is very limited for the phos-
phatase and phospho-binding proteins. Consequently, our knowledge of
signaling process is incomplete and heavily biased. A lot more work is
needed to elucidate the sequence motifs and other factors that affect
substrate speciﬁcity for phosphatase and interacting partners of phos-
phoproteins, and these will be the basis for the development of compu-
tational methods for prediction.
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